ANAB
Anaptysbio, Inc.
Clinical-stage biotechnology company focused on immunology therapeutics
CUSIP: 032724106HealthcareUS1 holder
Total Value
$47.87M
Total Shares
459.9K
Net Share Change
+459.9K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$47.87M459.9K sharesNEW